Heidelberg Pharma AG

Director's Dealing • Oct 13, 2022

News Details

Directors’ Dealings | 13 October 2022 12:53

EQS-DD: Heidelberg Pharma AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

13.10.2022 / 12:53 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	MH-LT-Investments GmbH

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr.
First name:	Mathias
Last name(s):	Hothum
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A11QVV0

b) Nature of the transaction

Sale to dievini Hopp BioTech holding GmbH & Co. KG due to contractual obligations

c) Price(s) and volume(s)

Price(s)	Volume(s)
6.44 EUR	506,241.96 EUR

d) Aggregated information

Price	Aggregated volume
6.4400 EUR	506,241.9600 EUR

e) Date of the transaction

2022-10-11; UTC+2

f) Place of the transaction

Outside a trading venue

---

13.10.2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Heidelberg Pharma AG
	Gregor-Mendel-Str. 22
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	EQS News Service